Abstract:Objective To explore the effect and mechanism of resveratrol ( RES) on the formation of glioblastoma cells in nude mice. Methods Ten 4-week-old female BALB/c nude mice were randomly divided into resveratrol group and dimethyl sulfoxide saline control group according to the number, with 5 mice in each group. Human malignant glioma U251 cell suspension was subcutaneously inoculated into the right forearm of nude mice by subcutaneous transplantation to establish a malignant glioma model in nude mice. On the 10th day after tumor implantation, tumor was obviously touched subcutaneously in the right forelimb of nude mice,indicating successful modeling. The mice in the resveratrol group were given 200 μL resveratrol solution at a concentration of 50 mmol/L. The nude mice in the control group were given the same concentration of dimethyl sulfoxide saline. Give the medicine once every three days for a total of 7 times. The longest diameter and the shortest diameter of the tumors were recorded before the first dose and the volume of the tumors was calculated. The tumor size was measured 3 days after each dose. The animals were killed after a final measurement of tumor size. Western blot was used to detect the expression of FOXP2 protein in resveratrol group and control group, and real-time fluorescence quantitative PCR ( qPCR) was used to detect the expression of microRNA-9. Results Ten nude mice in resveratrol group and control group were successfully established as transplanted malignant glioma models. The volume of tumors in the resveratrol group was (12. 94 ± 10. 17)mm3 on the 10th day after subcutaneous implantation of tumors, and that in the control group was (6. 46 ± 2. 67) mm3 . After the first, second, third and fourth administration, The volume of tumors in resveratrol group was (25. 58 ± 16. 41) mm3, (32. 33 ± 17. 62) mm3 , (58. 81 ± 7. 66) mm3, (97. 67 ± 20. 76) mm3 , respectively. The volume of tumors in control group was(12. 02 ± 8. 71)mm3, (30. 73 ± 15. 74) mm3 , (52. 88 ± 20. 03) mm3 , (88. 50 ± 37. 01) mm3 , respectively. The volume of tumors in resveratrol group was larger than that in control group, but the difference was not significant ( all P values >0. 05). After the 5th, 6th and 7th administration, the volume of tumors in resveratrol group was ( 114. 94 ± 29. 35 ) mm3 , ( 237. 42 ± 23. 3 ) mm3 and ( 231. 27 ± 12. 6 ) mm3 , respectively, which were smaller than those in control group ( 191. 71 ± 53. 79 ) mm3 , ( 314. 67 ± 24. 4) mm3 and(374. 03 ± 21. 6) mm3, with significant difference between the two groups ( t= -2. 802,-5. 114, -6. 320, all P values<0. 05). The relative expression of FOXP2 protein in resveratrol group (165. 51 ± 16. 31) was lower than that in control group (100. 60 ± 41. 75) and the difference was significant (t=3. 238, P<0. 05). The relative expression of microRNA-9 in resveratrol group (0. 971 ± 0. 369) was higher than that in control group (0. 496 ± 0. 008). The difference between the two groups was significant (t=2. 878, P<0. 05). Conclusions Resveratrol can inhibit the formation of glioblastoma cells in nude mice. The mechanism may be achieved by adjusting the miR-9-FOXP2 signal.

Resveratrol Inhibits Glioma Cell Growth Via Targeting Oncogenic Micrornas and Multiple Signaling Pathways

Resveratrol Inhibits Cell Growth and Induces Apoptosis of Rat C6 Glioma Cells

Enhanced growth inhibition effect of resveratrol incorporated into biodegradable nanoparticles against glioma cells is mediated by the induction of intracellular reactive oxygen species levels.

Resveratrol as an antitumor agent for glioblastoma multiforme: Targeting resistance and promoting apoptotic cell deaths

Research on Resveratrol's Effect in Suppressing Growth and Inducing Apoptosis of C6 Glioma Cells

Resveratrol Induces Glioma Cell Apoptosis through Activation of Tristetraprolin

Effect of Resveratrol on the Growth of Malignant Glioma in Nude Mice and Its Mechanism

Resveratrol, a potential radiation sensitizer for glioma stem cells both in vitro and in vivo

Resveratrol Induces Cancer Cell Apoptosis Through MiR-326/PKM2-Mediated ER Stress and Mitochondrial Fission.

Pak2 inhibition promotes resveratrol-mediated glioblastoma A172 cell apoptosis via modulating the AMPK-YAP signaling pathway.

Resveratrol Impairs Glioma Stem Cells Proliferation and Motility by Modulating the Wnt Signaling Pathway

Metabolic Patterns and Biotransformation Activities of Resveratrol in Human Glioblastoma Cells: Relevance with Therapeutic Efficacies

Effect of Resveratrol on Proliferation of Telmozolamine Resistant Glioblastoma and Mechanism

Resveratrol Suppresses Epithelial-Mesenchymal Transition in GBM by Regulating Smad-Dependent Signaling

Suppressive Effect of Resveratrol on Growth of U251 Human Glioma Cells and Its Correlated Mechanism

Experimental Study on Resveratrol Suppressing the Growth of SHG-44 Glioma Cells

Intratumor Injection of Thermosensitive Polypeptide with Resveratrol Inhibits Glioblastoma Growth

Inhibitory Effect of Resveratrol on Proliferation of U87 Cells and the Action Machanisam

Resveratrol Downregulates miR-155-5p to Block the Malignant Behavior of Gastric Cancer Cells

Resveratrol Inhibits Proliferation in HBL-52 Meningioma Cells

Bioactive Form of Resveratrol in Glioblastoma Cells and Its Safety for Normal Brain Cells